A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
2022 · Redox Biology · 18 citations
https://doi.org/10.1016/j.redox.2022.102358
N
Nicolas Prieto-Farigua
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
494
Citations
7
h-index
6
i10-index
Nicolas Prieto-Farigua is an academic researcher. The author has contributed to research in topics: Amino Acid Enzymes and Metabolism & Cancer, Hypoxia, and Metabolism & Genomics, phytochemicals, and oxidative stress. The author has an h-index of 7, co-authored 90 publications.
ORCID: 0000-0002-9138-8463Papers by this author
worksFigure S1 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25383340
Figure S5 from Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25383328.v1
Figure S3 from Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027620
Figure S5 from Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027614
Figure S2 from Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027623
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat